9 Papers
B. Catteau is an academic researcher from Lille University of Science and Technology. The author has contributed to research in topics: Medicine & Rash. The author has an hindex of 4, co-authored 6 publications.
Chat about Author
Papers
Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations.
Christine Bodemer,Christine Bodemer,Olivier Hermine,Olivier Hermine,Fabienne Palmerini,Ying Yang,Catherine Grandpeix-Guyodo,Phillip S. Leventhal,Smail Hadj-Rabia,Smail Hadj-Rabia,Laurent Nasca,Sophie Georgin-Lavialle,Annick Cohen-Akenine,Jean-Marie Launay,Stéphane Barete,Frédéric Féger,Michel Arock,B. Catteau,Beatrix Sans,J. F. Stalder,François Skowron,Luc Thomas,Gérard Lorette,Patrice Plantin,Pierre Bordigoni,Olivier Lortholary,Olivier Lortholary,Yves de Prost,Yves de Prost,Alain Moussy,Hagay Sobol,Hagay Sobol,Patrice Dubreuil +32 more
TL;DR: The findings strongly support the idea that, although pediatric mastocytosis can spontaneously regress, it is a clonal disease most commonly associated with activating mutations in c-KIT.
373
Treatment of two infants with PIK3CA-related overgrowth spectrum by alpelisib
Gabriel Morin,Caroline Degrugillier-Chopinet,Marie Vincent,A. Fraissenon,Hélène Aubert,Célia Chapelle,Clément Hoguin,François Dubos,B. Catteau,Florence Petit,Aurélie Mezel,Olivia Domanski,Guillaume Herbreteau,Marie Alesandrini,Nathalie Boddaert,Nathalie Boutry,Christine Broissand,Tianxiang Kevin Han,Fabrice Branle,Sabine Sarnacki,Thomas Blanc,Laurent Guibaud,Guillaume Canaud +22 more
TL;DR: The authors report the first description of two infants with PIK3CA-related overgrowth spectrum treated by alpelisib, associated with clinical, biological, and radiological improvements.
Unexpected extradermatological findings in 31 patients with xeroderma pigmentosum type C
Smail Hadj-Rabia,Smail Hadj-Rabia,Denis Oriot,Nadem Soufir,Nadem Soufir,H. Dufresne,H. Dufresne,Emmanuelle Bourrat,S. Mallet,N. Poulhalon,E. Ezzedine,Bernard Grandchamp,Alain Taïeb,B. Catteau,Alain Sarasin,Christine Bodemer,Christine Bodemer +16 more
TL;DR: Background Xeroderma pigmentosum type C (XP‐C) is a rare, autosomal, recessive condition characterized by the association of various clinical manifestations mostly involving the skin and eyes.
33
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Series of 49 French Pediatric Cases.
Eve Bedouelle,Benoit Ben Said,Florence Tetart,Brigitte Milpied,A. Welfringer-Morin,Annabel Maruani,B. Catteau,F. Dezoteux,Delphine Staumont-Sallé,Juliette Mazereeuw-Hautier,Claire Abasq,Christine Chiaverini,J. Delaunay,Stéphanie Mallet,B. Sterling,Eve Puzenat,Margot Raynal,Evelyne Collet,Claire Bernier +18 more
TL;DR: In this paper, the authors describe clinical and laboratory features of DRESS syndrome in the pediatric population (age ≤ 18 years) and establish causative agents and treatment modalities in 15 French university hospitals between 2000 and 2020.
25
Systematic search for neutropenia should be part of the first screening in patients with poikiloderma.
Juliette Piard,Muriel Holder-Espinasse,Bernard Aral,Nadège Gigot,Marlène Rio,Marc Tardieu,Eve Puzenat,Alice Goldenberg,Annick Toutain,Jerôme Franques,Kay MacDermot,Didier Bessis,Odile Boute,Patrick Callier,Lucie Gueneau,Frédéric Huet,Pierre Vabres,B. Catteau,Laurence Faivre,Christel Thauvin-Robinet +19 more
TL;DR: It is confirmed that neutrophil count should be performed in all patients with poikiloderma to target the C16orf57 gene sequencing analysis, prior to RECQL4 analysis.
23